S. 3974 · 117th Congress
Ending Discrimination in COVID–19 Treatments Act
- Stage
- In committee
- Sponsor
- Ted Cruz
- Introduced
- 2022-03-31
- Latest action
- 2022-03-31 · Introduced in Senate
Summary
Ending Discrimination in COVID-19 Treatments Act
This bill prohibits consideration of certain factors, including vaccination status, in decisions about an individual's access to federally provided monoclonal antibody therapies to treat COVID-19.
As a condition of receiving the therapies from the federal government, states must ensure that providers do not consider specified demographic characteristics, veteran status, or political ideology or speech when determining a patient's eligibility for such therapies.